/
Postpartum Hemorrhage Case Study Postpartum Hemorrhage Case Study

Postpartum Hemorrhage Case Study - PowerPoint Presentation

luanne-stotts
luanne-stotts . @luanne-stotts
Follow
544 views
Uploaded On 2017-05-24

Postpartum Hemorrhage Case Study - PPT Presentation

Providence Clinical Academy Obstetrics Curriculum Knowledge Check JoAnn a 25yearold G1P0 is induced with prolonged oxytocin at term for mild preeclampsia Her admission hematocrit is 39 and her platelet count is 190000µL Systolic blood pressure ranged from 154 to 142 mmHg and diastolic ID: 551642

loss blood providence clinical blood loss clinical providence academy obstetrics 2016 1500 case 2200 140 stage study cumulative 1700 2000 130 1600

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Postpartum Hemorrhage Case Study" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Postpartum Hemorrhage Case Study

Providence Clinical Academy: Obstetrics CurriculumSlide2

Knowledge Check

JoAnn, a 25-year-old G1P0, is induced with prolonged oxytocin at term for mild preeclampsia. Her admission hematocrit is 39% and her platelet count is 190,000/µL. Systolic blood pressure ranged from 154 to 142 mmHg and diastolic blood pressure from 98 to 88 mmHg prior to admission and during labor.

What risk factors for PPH do you see in this case? Choose all that apply.

Low platelets

Prolonged second stage of labor Use of prolonged oxytocin during the induction Epidural anesthesia History of preeclampsiaOperative vaginal delivery

2016.07

The labor epidural is placed at 5 cm of dilation. The physician uses low forceps for a prolonged (5

hr) second stage and delivers a 9 lb baby. After an uneventful delivery of the placenta, heavy vaginal bleeding ensues. Inspection of the placenta reveals no missing cotyledons and inspection of the lower genital tract reveals no lacerations or source of bleeding. Palpation of the uterus reveals severe atony.

Providence Clinical Academy: Obstetrics

2Slide3

Knowledge Check

Bimanual massage is initiated by the physician and IV oxytocin is infusing at a rapid rate. There is no immediate improvement in uterine tone.

Current vital signs are

: BP 130/75 mmHgP 96 bpm.

What medication should be ordered by physician at this point?Oxytocin IV push Methergine 2 mg IM Hemabate (carboprost) 0.25 mg IVCytotec (misoprostol) 800

2016.07Providence Clinical Academy: Obstetrics

3Slide4

Knowledge Check

Cytotec

is administered and uterus remains atonic. The EBL is 800 mL during the delivery and another 700

mL. Hemabate is ordered and administered. Current vital signs:

BP 119/69 mmHgP 108 bpmWhich of the following interventions would not be appropriate for JoAnn at this time? Choose all that apply.Vital signs and uterine assessment to q 5 minutesWeighing pads to accurately assess blood lossBimanual fundal massage STAT laboratory testing such as CBC, PT, PTT, fibrinogen

Order OB Hemorrhage PackContinue to monitor patient status in the room

2016.07

Providence Clinical Academy: Obstetrics4Slide5

Intervention & Management: Algorithm

STAGE 1

Cumulative Blood Loss

>500ml

vag birth or >1000ml C/S

OR Increased bleeding during recovery or postpartumSTAGE 2

Cumulative blood loss

1500 ml Continued bleedingPulse >120

Decreased BP

STAGE 3

Cumulative blood loss

>1500 ml

OR

Suspicion of DIC

Pulse >140

Decreased BP

2016.07

Providence Clinical Academy: Obstetrics

5Slide6

Stage 1

Cumulative Blood Loss >500ml vag birth>1000ml C/S OR

Increased bleeding during recovery or postpartum

Nursing Care:Establish IV access if not present, at least 18 gaugeIncrease Oxytocin and titrate to uterine toneContinue vigorous fundal massageAssess and empty bladder

Notify LIP/Charge NurseAdminister uterotonics as orderedVital Signs q 5-10 minutes including O2 sat & level of consciousnessWeigh, calculate and record cumulative blood loss Administer oxygen to maintain O2 sats at >95%Type and Screen (if not already done)Keep patient warmDocumentLIP:Methergine 0.2mg IM if not hypertensiveIf hypertensive give *Hemabate 250mcg IM or *Misoprostol 800mcg rectally Deferential Diagnosis - rule out retained products of conception, laceration, hematomaSurgeon: (if cesarean birth and still open)Inspect for uncontrolled bleeding at all levels, especially, broad ligament, posterior uterus, and retained placenta

2016.07Providence Clinical Academy: Obstetrics6Slide7

Stage 2

1500 mL cumulative blood loss and continued bleeding

Pulse >120, Decreased BP

Nursing Care:Start a 2nd IV and administer IV fluids (LR is preferred)Place Foley with urimeter

Continue assessing frequent vital signs and blood lossI & O Maintain communication with charge nurse Assists anesthesia provider Apply Bair Hugger and SCDs Administer medications as ordered Assist Anesthesia as neededDocumentLIP:Continue uterotonic medicationsMove to the OR- D/C, tamponade balloon, uterine packingOrder OB Hemorrhage PanelType & Cross for 2 units PRBCs or OB Hemorrhage Pack (if patient bleeding is not responding to treatment and interventionsInterventions follow underlying cause for bleedingLaborist Anesthesia:Monitor patient vital signsProvide pain reliefBegin blood replacement as indicated

2016.07

Providence Clinical Academy: Obstetrics

7Slide8

Stage 3

Cumulative blood loss >1500 OR Pulse >140, Decreased BP Suspicion of DIC

Nursing Care:

Maintains communication with team membersAdminister medications as ordered Set up cell saver

Assists anesthesia as neededMonitor cumulative blood loss and update teamDocumentDraw labs LIP:Order OB Hemorrhage PackUterotonics Call for GYN/ONC and/or Adult IntensivistConsider uterine artery ligation, interventional radiology, or hysterectomyAnesthesia:Monitor frequent vital signs and communicate to teamArterial blood gases and repeat OB Hemorrhage PanelPlace central line as needed Continue to administer meds and blood products

2016.07Providence Clinical Academy: Obstetrics8Slide9

APPLY WHAT YOU LEARNED

Postpartum Hemorrhage Case Study

2016.07

Providence Clinical Academy: Obstetrics

9Slide10

Case Study: Background Information

34 y.o. G2 P1001, 39 1/7 weeks

Planned, repeat C/S

A Neg/ Rubella Pos/ Hepatitis B Neg/ RPR non-reactiveUneventful prenatal courseNo pertinent medical history16 g IV placed in left wrist Cefazolin 2 gms IV pre-op

2016.07

Providence Clinical Academy: Obstetrics10Slide11

Case Study: Background Information

What would this patient’s risk factors be for PPH?

What labs should be drawn pre-op?

Prior C/S (Trauma)

CBCType & Screen

2016.07Admission Hct 36.9TySc sentProvidence Clinical Academy: Obstetrics11Slide12

2016.07

Cumulative Blood Loss

0

mL

140

130

120

110

100

90

80

70

60

150

HR 70

1500

1600

1700

1800

1900

2000

2100

2200

BP 105/52

HR 90

1533

C/S delivery

BP 116/68

1536

Oxytocin 20 units in 1 L LR

Case Study

Providence Clinical Academy: Obstetrics

12Slide13

2016.07

Case Study

Cumulative Blood Loss

1000+ mL

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

BP 107/50

HR 76

1545- Persistent bleeding noted on uterine layer, fundus firm, figure 8 stitch placed

1600 – Admit to

recovery room

EBL 1200 ml per anesthesia, < 1000 ml per surgeon

Providence Clinical Academy: Obstetrics

13Slide14

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

1630 – Nursing Note

“large clots expressed MD called to bedside”

1645 Return to the OR

BP 100/48

HR 105

1615- Nursing note

“large clot expressed oozing , fundus boggy firmed with massage “

1615-1620

Methergine 200 mcg IM Misoprostol 800 mcg PR

Cumulative Blood Loss

1000+ mL

Providence Clinical Academy: Obstetrics

14Slide15

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

1700 D&C, EBL noted at 500 ml

1715

Bakri balloon placed

Active bleeding stopped

1715

Hemabate 250 mcg IM

1730

T&C for 4 units

CBC, Coags drawn

BP 98/50

HR 115

Cumulative Blood Loss

1500+ mL

Providence Clinical Academy: Obstetrics

15Slide16

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

Oxytocin

30 units in 500

mL

1840

Hct 32.5

Platelets 129

Fibrinogen 205

1745

Bleeding slowed to minimal

HR 140

Cefazolin

2 gm IV

BP 95/60

Cumulative Blood Loss

1500+ mL

Providence Clinical Academy: Obstetrics

16Slide17

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

HR 150

1945

200 mL noted in Bakri Balloon

Fundus 3-5 cm above umbilicus

Abdomen tender

BP 89/45

2000

Hct 26.9

Platelets 131

Fibrinogen 151

1955

OB at bedside

U/S done – shows large clot

2015

Hct 21 per I-Stat

Cumulative Blood Loss

1700+ mL

Providence Clinical Academy: Obstetrics

17Slide18

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

2045

Midazolam

and

Fentanyl

for sedation

2030

Pt transferred to interventional radiology

“moderate amount of bleeding continues”

2140 Bilateral uterine artery embolization.

Hemostatsis achieved. 500 ml blood loss into Bakri Balloon

2015 1 unit PRBCs

2130 1 unit PRBCs

2100 1 unit PRBCs

HR 140

2055

Hemorrhage pack ordered

BP 80/39

Cumulative Blood Loss

2200+ mL

Providence Clinical Academy: Obstetrics

18Slide19

2016.07

Case Study

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

2250

Cryoprecipitate

2300

Cryoprecipitate, and 1 unit PRBCs

HR 125

BP 92/64

2245

4-pack FFP

2225

4-pack FFP

2200

4-pack FFP

2200

Transferred to recovery

Cumulative Blood Loss

2200+ mL

Providence Clinical Academy: Obstetrics

19Slide20

Case Study: Conclusion

The patient remained stable in recovery after the uterine artery embolization with scant lochia rubra then transferred to ICU after recovery

Labs were the following:

0000Hct 30.6, WBC 24.9, Platelets 88, Fibrinogen 1640400

Hct 29.1, WBC 19.1, Platelets 75, Fibrinogen 1990730Hct 28.6, WBC 15.9, Platelets 67, Fibrinogen 226Bakri Balloon removed at noon post-op day #1 with 200 mL blood loss in bag Total EBL = ???Pt transferred in stable condition to postpartum at 1500Discharged to home on post-op day #5

2016.07Providence Clinical Academy: Obstetrics20Slide21

Which of these common mistakes occurred in this case?

Treating postpartum hemorrhage as a diagnosis and not identifying the cause

Underestimation of blood loss

Inattention to vital sign trendsDelay in intervening surgically if neededDelay in laboratory assessmentDelay in instituting blood replacement therapyDelay in moving from “normal delivery” to “life threatening emergency”Poor communication between nurse and OB providers on amount of blood loss, vital signs and other clinical indicatorsLack of communication between OB provider and anesthesia who is managing blood loss and replacement therapy Insufficient preoperative preparation for massive hemorrhage (placenta previa, known or suspected accreta)

2016.07

Providence Clinical Academy: Obstetrics

21Slide22

Case Study Reflection

Underestimation of blood loss- it was difficult to determine cumulative blood loss during this case. The RN should of weighed blood loss and a cumulative total should have been noted.

Inattention to vital signs and delay in instituting blood replacement therapy - the patient was tachycardic an hypotensive, blood replaced was delayed until laboratory values reflected the need for blood replacement.

2016.07

Providence Clinical Academy: Obstetrics

22Slide23

2016.07

Cumulative Blood Loss

0

mL

140

130

120

110

100

90

80

70

60

150

HR 70

1500

1600

1700

1800

1900

2000

2100

2200

BP 105/52

HR 90

1533

C/S delivery

BP 116/68

1536

Oxytocin 20 units in 1 L LR

Case Study: Stage 0

Providence Clinical Academy: Obstetrics

23Slide24

2016.07

Case Study: Stage 1

Cumulative Blood Loss

1000+ mL

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

BP 107/50

HR 76

1545- Persistent bleeding noted on uterine layer, fundus firm, figure 8 stitch placed

1600 – Admit to

recovery room

EBL 1200 ml per anesthesia, < 1000 ml per surgeon

Stage 1:

Greater than 1000

mL

blood loss with stable vital signs

Exact blood loss unknown as laps have not been weighed

Oxytocin

should be increased

Providence Clinical Academy: Obstetrics

24Slide25

Case Study: Stage 2

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

1630 – Nursing Note

“large clots expressed MD called to bedside”

1645 Return to the OR

BP 100/48

HR 105

1615- Nursing note

“large clot expressed oozing , fundus boggy firmed with massage “

1615-1620

Methergine 200 mcg IM Misoprostol 800 mcg PR

Cumulative Blood Loss

1000+ mL

Stage 2:

Less than 1500

mL

blood loss & continued bleeding & decreased BP/elevated HR

Need a 2

nd

IV

OB Hemorrhage

labs

and at least 2 units of PRBCs should be ordered

Increase

Oxytocin

rate

Give

Hemabate

and repeat all Uterotonics per guidelines

Providence Clinical Academy: Obstetrics

25Slide26

Case Study: Stage 3

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

1700 D&C, EBL noted at 500 ml

1715

Bakri balloon placed

Active bleeding stopped

1715

Hemabate 250 mcg IM

1730

T&C for 4 units

CBC, Coags drawn

BP 98/50

HR 115

Cumulative Blood Loss

1500+ mL

Stage 3:

Greater than 1500

mL

blood loss

2

nd

IV, labs, and PRBCs should have already been ordered

Hemabate

may be repeated q 15-90

mins

x 8

Providence Clinical Academy: Obstetrics

26Slide27

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

Oxytocin

30 units in 500

mL

1840

Hct 32.5

Platelets 129

Fibrinogen 205

1745

Bleeding slowed to minimal

HR 140

Cefazolin

2 gm IV

BP 95/60

Cumulative Blood Loss

1500+ mL

Stage 3:

Greater than 1500

mL

blood loss

Methergine

may be repeated q 2-4 hours x 5 (only given 1x at this point)

Hemabate

may be repeated q 15-90

mins

x 8 (only given x1 at this point)

OB Hemorrhage

blood products

should be ordered

Case Study: Stage 3

Providence Clinical Academy: Obstetrics

27Slide28

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

1945

200 mL noted in Bakri Balloon

Fundus 3-5 cm above umbilicus

Abdomen tender

BP 89/45

2000

Hct 26.9

Platelets 131

Fibrinogen 151

1955

OB at bedside

U/S done – shows large clot

2015

Hct 21 per I-Stat

Stage 3:

Greater than 1500

mL

blood loss

Methergine

may be repeated q 2-4 hours x 5 (only given 1x at this point)

Hemabate

may be repeated q 15-90

mins

x 8 (only given x1 at this point)

OB Panel to be repeated q 30

mins

(this was done 1 hour ago at this point)

No blood has yet been transfused at this time (Type & Cross for 4 units ordered at 1730)

Cumulative Blood Loss

1700+ mL

Case Study: Stage 3

HR 150

Providence Clinical Academy: Obstetrics

28Slide29

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

2045

Midazolam

and

Fentanyl

for sedation

2030

Pt transferred to interventional radiology

“moderate amount of bleeding continues”

2140 Bilateral uterine artery embolization.

Hemostatsis achieved. 500 ml blood loss into Bakri Balloon

2015 1 unit PRBCs

2130 1 unit PRBCs

2100 1 unit PRBCs

HR 140

2055

Hemorrhage pack ordered

BP 80/39

Cumulative Blood Loss

2200+ mL

Stage 3:

1

st

unit of PRBCs given 3 hours after it was ordered

Still only 1 dose of

Hemabate

and

Methergine

given at this time

OB Hem

blood products

ordered

5

hours after start of Stage 3

Case Study: Stage 3

Providence Clinical Academy: Obstetrics

29Slide30

2016.07

140

130

120

110

100

90

80

70

60

150

1500

1600

1700

1800

1900

2000

2100

2200

2250

Cryoprecipitate

2300

Cryoprecipitate, and 1 unit PRBCs

HR 125

BP 92/64

2245

4-pack FFP

2225

4-pack FFP

2200

4-pack FFP

2200

Transferred to recovery

Cumulative Blood Loss

2200+ mL

Stage 3:

Still no other

uterotonics

administered

No labs since 2015

OB Hem Panel to be done q 30

mins

in PPH

Case Study: Stage 3

Providence Clinical Academy: Obstetrics

30Slide31

Knowledge Check

After C/S delivery Sarah is transferred to the OB/PACU.

The 2

nd PP check reveals: BP 99/50Pulse 126RR 20

Temp 98.2° F (oral)The abdominal dressing is C, D, & IFF @ 2 cm below Abdomen palpates slightly distendedPatient complains of slight nausea. What are the possible physiologic reasons for Sarah’s current condition? (choose all that apply)Nausea due to ice chips Tachycardia related to pain, repositioning, and movement during transfer from OB/PACU to postpartum Possible internal bleeding

2016.07

Providence Clinical Academy: Obstetrics

31Slide32

Knowledge Check

At the next assessment:

Sarah’s fundus is difficult to palpate.

Abd dressing C, D, & I Lochia is scant. BP 88/50 mmHg Pulse is 130 bpm.

After administration of an antiemetic, Sarah starts vomiting and her skin is clammy to touch. She says she feels weak and cold.Nursing interventions should include all of the following EXCEPT?Request a bedside assessment by the charge nurse Request a bedside assessment by the physician Request an order to type and crossmatch the patientAdminister additional antiemetics Bolus with IV fluids Prepare to start second IV line for access

2016.07

Providence Clinical Academy: Obstetrics

32Slide33

Knowledge Check

Sarah's physician is at the bedside.

BP 85/30 mmHg

P 140 bpmThere is no new urine outputLochia is scant. ABD dressing is C,D, & I.

The abdomen is distended and the uterus cannot be palpated. Sarah now rates her pain at 7. What should be the next management plan? (choose all that apply)Notify anesthesia and immediately transfer to OR Continue to monitor, blood pressure, and pulse oximetry monitors Run IV of LR wide open to increase her fluid volume Administer 2 units of blood emergently without verification Order OB Hemorrhage labsApply oxygen via non-rebreather face mask

2016.07

Providence Clinical Academy: Obstetrics

33Slide34

Knowledge Check

When the surgery starts, the obstetrician finds Sarah’s abdomen full of blood.

The LIP found the left uterine artery is lacerated. The bleeding is controlled with additional suturing.

After suctioning, the canister contains 1500 mL of blood. Capillary oozing is visible. The lab results will be available in 5 minutes. BP 80/42 mmHgPulse is 140 bpm.

What transfusion orders should be given at this time? (choose all that apply)Transfuse 4 units of PRBC now and anticipate an order for 2 additional unitsTransfuse 1 unit of PRBC pending lab results Thaw fresh frozen plasma and give as soon as available Give 1 unit of pooled platelets Give recombinant factor VIIa

2016.07

Providence Clinical Academy: Obstetrics

34Slide35

Knowledge Check

Sarah’s active bleeding has subsided and there is only slight capillary oozing after the laparotomy.

Initial PACU lab values include:

Hct 20%Fibrinogen 60 mg/dL

Platelets 55,000/µL Core temp 96.2°FBP 104/58 mmHg Pulse 112 bpm. Further management of this patient should include? (choose all that apply)Anticipate that more blood and blood products will be ordered and administered Apply warming unit to the patient (warming blankets such as Bear Hugger®)Strict input and output records Follow PACU protocol

2016.07

Providence Clinical Academy: Obstetrics

35